Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Reminder: Invitation to Roche's Full Year Results 2016 Mittwoch, 18. Januar 2017 - 14:10

Roche - Investor Update

Basel, 18 January 2017
Reminder: Invitation to Roche's Full Year Results 2016
Roche will publish its Full Year Results for 2016 prior to the opening of the Swiss Stock Exchange on Wednesday, 1 February 2017.
7:00 CET / 6:00 GMT / 1:00 AM EST / 10:00 PM PST (evening before)
Release will be e-mailed and posted on the Roche IR website icon_link_inline.gifclick here.
Presentation slides will be posted on the Roche IR website icon_link_inline.gifclick here.
We would like to invite all interested parties to participate or dial in to the event outlined below.
Upicon_up.gif
hruler_large.gif

Wednesday, 1 February 2017, London

 
The Full Year Presentation followed by Q&A and additional break-out sessions will be held at the London Stock Exchange, The Theatre, 10 Paternoster Square, London EC4M 7LS > map

Presenters:

icon_bull.gifSeverin Schwan, CEO Roche Group
icon_bull.gifDaniel O'Day, CEO Roche Pharmaceuticals
icon_bull.gifRoland Diggelmann, CEO Roche Diagnostics
icon_bull.gifAlan Hippe, Chief Financial and IT Officer

Meeting information:

contact_date.gifDownload to my calendar
Date: 1 February 2017
Time (GMT): 
14:30 Registration 
15:00 Meeting starts 
17:30 Meeting ends, followed by a buffet reception
Break-out sessions covering the topics Strategy, Finance & Accounting, Pharmaceuticals and Diagnostics will be held following the main Q&A.
Following the event we would also like to invite you to drinks and canapes to give you the opportunity to speak to management more informally.
Please make sure you have identification and allow enough time to go through the London Stock Exchange security check.
To register for the event, please follow the > link 
This presentation can also be accessed through a live video webcast: 
> http://ir.roche.com.
Alternatively, you may dial in to the conference, using the following dial-in numbers (listen-only mode, no live-access to speakers), 10-15 minutes prior to the scheduled start:
+41 (0) 58 310 5000 (Europe and ROW) or
+44 (0) 203 059 5862 (UK) or
+1 (1) 631 570 5613 (USA)
To expedite the registration process on the day of the event, you may pre-register for the conference call. > click here.

Replay

 
A replay of the video webcast will be available on demand on the Roche website.> click here.
 
Best regards,
Karl Mahler
Head of Investor Relations
Upicon_up.gif
hruler_large.gif
Roche Investor Relations
Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com
Dr. Sabine Borngräber 
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com
Dr. Tamer Farhan 
Phone: +41 61 68-82552 
e-mail: tamer.farhan@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com
Dr. Susann Weissmüller
Phone: +41 61 68-84814 
e-mail: susann.weissmueller@roche.com
Investor Relations North America
Neera Dahiya Ravindran, MD 
Phone: +1 650 491 5281 
e-mail: ravindran.neera@gene.com
Loren Kalm 
Phone: +1 650 225 3217 
e-mail: kalm.loren@gene.com
18 January, 2017 Content owner:   icon_link_inline999.gifRoche Investor Relations    ©2017 F. Hoffmann-La Roche Ltd.